Curious to see the emissions of the organizations you buy from or invest in?
Book a demo for a pilot project
SK Biopharmaceuticals
Pharmaceutical Preparation ManufacturingSouth KoreaKSC: 326030.KS
Last verified 23 days agoskbp.com
SK Biopharmaceuticals, a leading player in the pharmaceutical preparation manufacturing industry, is headquartered in South Korea (KR). Founded in 2011, the company has rapidly established itself as a key innovator in the development of novel therapeutics, particularly in the fields of neurology and oncology.
With a strong focus on research and development, SK Biopharmaceuticals offers a range of unique products, including innovative treatments that address unmet medical needs. The company has achieved significant milestones, including successful global partnerships and the launch of groundbreaking therapies that enhance patient outcomes.
Recognised for its commitment to quality and innovation, SK Biopharmaceuticals continues to strengthen its market position, contributing to advancements in healthcare both domestically and internationally.
44
DitchCarbon score
+2 vs industry average
SK Biopharmaceuticals’s score of 44 is higher than 55% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at SK Biopharmaceuticals?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Very Low
Pharmaceutical Preparation Manufacturing is among the least carbon-intensive industries
Industry performance
0.243
02025
The Pharmaceutical Preparation Manufacturing industry has increased its overall emissions by 132% since 0
Emissions trajectory 2020 – 2026
2020202120222023202420252026
Reported emissions
Scope 1
•••kg CO₂e
Scope 2
•••kg CO₂e
Scope 3
•••kg CO₂e
Total reported
•••kg CO₂e
Scope 3 accounts for ••• of total emissions.
SK Biopharmaceuticals's reported carbon emissions
SK Biopharmaceuticals, a Pharmaceutical Preparation Manufacturing company headquartered in KR, reported its 2023 carbon emissions. In 2023, the company's Scope 1 emissions were approximately 433,000 kg CO2e, Scope 2 emissions were around 1,046,000 kg CO2e, and Scope 3 emissions totalled approximately 11,882,000 kg CO2e. This marks an increase in Scope 3 emissions compared to 2022, which were about 6,547,000 kg CO2e. For 2022, Scope 1 emissions were 425,000 kg CO2e and Scope 2 emissions were 936,000 kg CO2e. The company also disclosed Scope 1 and 2 emissions for previous years: approximately 1,349,000 kg CO2e in 2021, 1,211,000 kg CO2e in 2020, and 1,105,000 kg CO2e in 2019. SK Biopharmaceuticals has not yet reported any specific, public reduction targets or commitments, nor does it participate in initiatives like SBTi or The Climate Pledge. Emissions data is directly reported by SK Biopharmaceuticals Co., Ltd.
Assessing SK Biopharmaceuticals as a supplier or portfolio company?
- See verified emissions data for over 2 million organizations
- View emissions forecasts for SK Biopharmaceuticals and the organizations you buy from or invest in
- Get PCAF data quality (DQ) scores, including for private organizations
SK Biopharmaceuticals’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for SK Biopharmaceuticals yet.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Climate initiatives
Science Based Targets Initiative
Inherited from SK Inc.See details
Not active
Carbon Disclosure Project
Sign in to view
Active
The Climate Pledge
See details
Not active
UN Global Compact Climate Champions initiative
See details
Not active
RE 100
See details
Not active
Climate Action 100
See details
Not active
Emissions comparison with industry peers
View similar organisationsCompanyCountryIndustryLast updatedScoreDetails
SK Biopharmaceuticals23 days ago
44
Need this data for financed emissions?
PCAF scored Scope 1, 2 and 3 for 2M+ organizations, including private ones.
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more